BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12643749)

  • 1. Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores.
    Kobayashi H; Kawamoto S; Jo SK; Bryant HL; Brechbiel MW; Star RA
    Bioconjug Chem; 2003; 14(2):388-94. PubMed ID: 12643749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyamine dendrimer-based MRI contrast agents for functional kidney imaging to diagnose acute renal failure.
    Kobayashi H; Jo SK; Kawamoto S; Yasuda H; Hu X; Knopp MV; Brechbiel MW; Choyke PL; Star RA
    J Magn Reson Imaging; 2004 Sep; 20(3):512-8. PubMed ID: 15332261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micro-MR angiography of normal and intratumoral vessels in mice using dedicated intravascular MR contrast agents with high generation of polyamidoamine dendrimer core: reference to pharmacokinetic properties of dendrimer-based MR contrast agents.
    Kobayashi H; Kawamoto S; Saga T; Sato N; Hiraga A; Konishi J; Togashi K; Brechbiel MW
    J Magn Reson Imaging; 2001 Dec; 14(6):705-13. PubMed ID: 11747027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core.
    Kobayashi H; Kawamoto S; Saga T; Sato N; Hiraga A; Ishimori T; Akita Y; Mamede MH; Konishi J; Togashi K; Brechbiel MW
    Magn Reson Med; 2001 Oct; 46(4):795-802. PubMed ID: 11590657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores.
    Sato N; Kobayashi H; Hiraga A; Saga T; Togashi K; Konishi J; Brechbiel MW
    Magn Reson Med; 2001 Dec; 46(6):1169-73. PubMed ID: 11746584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography.
    Kobayashi H; Kawamoto S; Choyke PL; Sato N; Knopp MV; Star RA; Waldmann TA; Tagaya Y; Brechbiel MW
    Magn Reson Med; 2003 Oct; 50(4):758-66. PubMed ID: 14523962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of Chiral Dendrimer-Triamine-Coordinated Gd-MRI Contrast Agents Evaluated by in Vivo MRI and Estimated by in Vitro QCM.
    Miyake Y; Ishikawa S; Kimura Y; Son A; Imai H; Matsuda T; Yamada H; Toshimitsu A; Kondo T
    Sensors (Basel); 2015 Dec; 15(12):31973-86. PubMed ID: 26694418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the macromolecular MR contrast agents with ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer.
    Kobayashi H; Sato N; Kawamoto S; Saga T; Hiraga A; Haque TL; Ishimori T; Konishi J; Togashi K; Brechbiel MW
    Bioconjug Chem; 2001; 12(1):100-7. PubMed ID: 11170372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano-sized MRI contrast agents with dendrimer cores.
    Kobayashi H; Brechbiel MW
    Adv Drug Deliv Rev; 2005 Dec; 57(15):2271-86. PubMed ID: 16290152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gadolinium-labeled peptide dendrimers with controlled structures as potential magnetic resonance imaging contrast agents.
    Luo K; Liu G; She W; Wang Q; Wang G; He B; Ai H; Gong Q; Song B; Gu Z
    Biomaterials; 2011 Nov; 32(31):7951-60. PubMed ID: 21784511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium MRI contrast agents based on triazine dendrimers: relaxivity and in vivo pharmacokinetics.
    Lim J; Turkbey B; Bernardo M; Bryant LH; Garzoni M; Pavan GM; Nakajima T; Choyke PL; Simanek EE; Kobayashi H
    Bioconjug Chem; 2012 Nov; 23(11):2291-9. PubMed ID: 23035964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vivo evaluation of a PAMAM-cystamine-(Gd-DO3A) conjugate as a biodegradable macromolecular MRI contrast agent.
    Xu R; Wang Y; Wang X; Jeong EK; Parker DL; Lu ZR
    Exp Biol Med (Maywood); 2007 Sep; 232(8):1081-9. PubMed ID: 17720954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics.
    Kojima C; Turkbey B; Ogawa M; Bernardo M; Regino CA; Bryant LH; Choyke PL; Kono K; Kobayashi H
    Nanomedicine; 2011 Dec; 7(6):1001-8. PubMed ID: 21515406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel intravascular macromolecular MRI contrast agent with generation-4 polyamidoamine dendrimer core: accelerated renal excretion with coinjection of lysine.
    Kobayashi H; Sato N; Kawamoto S; Saga T; Hiraga A; Ishimori T; Konishi J; Togashi K; Brechbiel MW
    Magn Reson Med; 2001 Sep; 46(3):457-64. PubMed ID: 11550236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
    Fu Y; Raatschen HJ; Nitecki DE; Wendland MF; Novikov V; Fournier LS; Cyran C; Rogut V; Shames DM; Brasch RC
    Biomacromolecules; 2007 May; 8(5):1519-29. PubMed ID: 17402781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive effects of polyethylene glycol conjugation to generation-4 polyamidoamine dendrimers as macromolecular MR contrast agents.
    Kobayashi H; Kawamoto S; Saga T; Sato N; Hiraga A; Ishimori T; Konishi J; Togashi K; Brechbiel MW
    Magn Reson Med; 2001 Oct; 46(4):781-8. PubMed ID: 11590655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic micro-magnetic resonance imaging of liver micrometastasis in mice with a novel liver macromolecular magnetic resonance contrast agent DAB-Am64-(1B4M-Gd)(64).
    Kobayashi H; Saga T; Kawamoto S; Sato N; Hiraga A; Ishimori T; Konishi J; Togashi K; Brechbiel MW
    Cancer Res; 2001 Jul; 61(13):4966-70. PubMed ID: 11431325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-micro-MR angiography of mice using macromolecular MR contrast agents with polyamidoamine dendrimer core with reference to their pharmacokinetic properties.
    Kobayashi H; Sato N; Hiraga A; Saga T; Nakamoto Y; Ueda H; Konishi J; Togashi K; Brechbiel MW
    Magn Reson Med; 2001 Mar; 45(3):454-60. PubMed ID: 11241704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
    Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
    Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
    Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
    J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.